Reviewing Ampco-Pittsburgh


Ampco-Pittsburgh and TriMas are both small-cap industrial products companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk. Ampco-Pittsburgh currently has a consensus price target of $22.00, indicating a potential upside of 126.80%.



from Biotech News